We are live on
!
Find out more
JGUA
John G. Ullman & Associates Portfolio holdings
AUM
$754M
1-Year Est. Return
60.05%
This Fund
S&P 500
This Quarter
Est. Return
+0.09%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$479M
AUM Growth
–
Cap. Flow
+$487M
Cap. Flow
% of AUM
101.67%
Top 10 Holdings %
Top 10 Hldgs %
31.19%
Holding
150
New
150
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$28.4M |
| 2 |
ExxonMobil
XOM
|
+$19.5M |
| 3 |
Corning
GLW
|
+$19.3M |
| 4 |
Emerson Electric
EMR
|
+$13.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$13.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.79% |
| 2 | Industrials | 14.86% |
| 3 | Technology | 14.53% |
| 4 | Utilities | 9.74% |
| 5 | Energy | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$599B
| $28.8M | 6% |
+334,912
| New | +$28.4M |
|
|
2
ExxonMobil
XOM
$615B
| $19.6M | 4.09% |
+216,967
| New | +$19.5M |
|
|
3
Corning
GLW
$132B
| $18.8M | 3.93% |
+1,323,824
| New | +$19.3M |
|
|
4
Bristol-Myers Squibb
BMY
$123B
| $13.8M | 2.88% |
+308,664
| New | +$13.4M |
|
|
5
Emerson Electric
EMR
$76.5B
| $13.3M | 2.77% |
+243,540
| New | +$13.7M |
|
6
Coca-Cola
KO
$353B
| $12.2M | 2.54% |
+303,192
| New | +$12.6M |
|
7
Intel
INTC
$488B
| $11.7M | 2.44% |
+483,217
| New | +$11.4M |
|
|
PLL
8
DELISTED
PALL CORP
PLL
| $10.9M | 2.27% |
+163,382
| New | +$11.1M |
|
9
SLB Ltd
SLB
$69.4B
| $10.6M | 2.22% |
+148,048
| New | +$11M |
|
10
GSK
GSK
$100B
| $9.78M | 2.04% |
+156,496
| New | +$9.93M |
|
11
Merck
MRK
$307B
| $9.4M | 1.96% |
+212,203
| New | +$9.48M |
|
12
Microsoft
MSFT
$2.99T
| $9.24M | 1.93% |
+267,390
| New | +$8.76M |
|
|
GXP
13
DELISTED
Great Plains Energy Incorporated
GXP
| $9.22M | 1.93% |
+409,090
| New | +$9.51M |
|
14
Pfizer
PFE
$141B
| $9.15M | 1.91% |
+344,185
| New | +$9.51M |
|
15
Idacorp
IDA
$8.15B
| $9.03M | 1.88% |
+188,975
| New | +$9.09M |
|
16
Amgen
AMGN
$197B
| $8.65M | 1.81% |
+87,663
| New | +$9.1M |
|
17
Honeywell
HON
$71.7B
| $8.63M | 1.8% |
+120,996
| New | +$8.34M |
|
18
Duke Energy
DUK
$98.1B
| $8.29M | 1.73% |
+122,741
| New | +$8.68M |
|
19
Granite Construction
GVA
$5.34B
| $7.3M | 1.52% |
+245,342
| New | +$7.25M |
|
20
3M
MMM
$83B
| $7.13M | 1.49% |
+78,009
| New | +$7.08M |
|
21
Novartis
NVS
$285B
| $7.13M | 1.49% |
+112,482
| New | +$7.32M |
|
22
BCE
BCE
$20.2B
| $6.94M | 1.45% |
+169,178
| New | +$7.66M |
|
23
Exelon
EXC
$47B
| $6.92M | 1.44% |
+314,118
| New | +$7.62M |
|
|
DRC
24
DELISTED
DRESSER-RAND GROUP INC
DRC
| $5.84M | 1.22% |
+97,360
| New | +$5.76M |
|
25
Analog Devices
ADI
$181B
| $5.83M | 1.22% |
+129,395
| New | +$5.83M |
|
Similar funds
HCM
FSCM
SF
MSWM
RMC
BEC
GFM
TPW
John G. Ullman & Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for John G. Ullman & Associates, which disclosed 150 positions worth $479M. Its ten largest holdings account for 31% of the portfolio.
Its largest position is Johnson & Johnson: 334,912 shares worth $28.8M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, followed by Industrials and Technology.
- John G. Ullman & Associates's largest Q2 2013 buy was Johnson & Johnson: 334,912 shares worth $28.8M.
- John G. Ullman & Associates's ten largest holdings make up 31% of its $479M portfolio in Q2 2013.
- John G. Ullman & Associates disclosed 150 positions in Q2 2013, its first 13F filing on record.
Based on John G. Ullman & Associates's 13F filing for Q2 2013, filed 14 Aug 2013.